Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lensar Inc (LNSR)

Lensar Inc (LNSR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 85,719
  • Shares Outstanding, K 11,615
  • Annual Sales, $ 42,160 K
  • Annual Income, $ -14,380 K
  • EBIT $ -11 M
  • EBITDA $ -8 M
  • 60-Month Beta 0.59
  • Price/Sales 2.05
  • Price/Cash Flow N/A
  • Price/Book 3.80

Options Overview Details

View History
  • Implied Volatility 89.53% ( -0.54%)
  • Historical Volatility 74.68%
  • IV Percentile 41%
  • IV Rank 21.72%
  • IV High 396.43% on 04/03/24
  • IV Low 4.38% on 01/17/24
  • Put/Call Vol Ratio 0.63
  • Today's Volume 26
  • Volume Avg (30-Day) 50
  • Put/Call OI Ratio 4.21
  • Today's Open Interest 756
  • Open Int (30-Day) 704

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +153,792.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.28 +40.91%
on 11/01/24
8.17 -8.94%
on 11/21/24
+2.14 (+40.38%)
since 10/25/24
3-Month
3.80 +95.78%
on 09/16/24
8.17 -8.94%
on 11/21/24
+2.89 (+63.52%)
since 08/26/24
52-Week
2.12 +250.94%
on 12/12/23
8.17 -8.94%
on 11/21/24
+5.04 (+210.00%)
since 11/24/23

Most Recent Stories

More News
LENSAR, Inc. CEO Nick Curtis to Participate in BTIG 4th Annual Ophthalmology Day Fireside Chat

LENSAR CEO Nick Curtis will speak at BTIG Ophthalmology Day, with 1-on-1 investor meetings.Quiver AI SummaryLENSAR, Inc., a medical technology company specializing in robotic laser solutions for cataract...

LNSR : 7.44 (+1.09%)
LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

LNSR : 7.44 (+1.09%)
LENSAR Reports Third Quarter 2024 Results and Provides Business Update

LNSR : 7.44 (+1.09%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 7.44 (+1.09%)
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

LNSR : 7.44 (+1.09%)
One Millionth Procedure Completed Using LENSAR’s Cataract Laser Systems

LNSR : 7.44 (+1.09%)
LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 7.44 (+1.09%)
LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 7.44 (+1.09%)
LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 7.44 (+1.09%)
LENSAR to Present at Two Upcoming Investor Conferences

LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 7.44 (+1.09%)

Business Summary

LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida.

See More

Key Turning Points

3rd Resistance Point 8.39
2nd Resistance Point 8.14
1st Resistance Point 7.79
Last Price 7.44
1st Support Level 7.19
2nd Support Level 6.94
3rd Support Level 6.59

See More

52-Week High 8.17
Last Price 7.44
Fibonacci 61.8% 5.86
Fibonacci 50% 5.14
Fibonacci 38.2% 4.43
52-Week Low 2.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar